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Abstract
Background: Genome-wide surveys have detected cis-acting quantitative trait loci altering levels of RNA transcripts
(RNA-eQTLs) by associating SNV alleles to transcript levels. However, the sensitivity and specificity of detection of
cis- expression quantitative trait loci (eQTLs) by genetic approaches, reliant as it is on measurements of transcript
levels in recombinant inbred strains or offspring from arranged crosses, is unknown, as is their relationship to QTL’s
for complex phenotypes.
Results: We used transcriptome-wide differential allele expression (DAE) to detect cis-eQTLs in forebrain and kidney
from reciprocal crosses between three mouse inbred strains, 129S1/SvlmJ, DBA/2J, and CAST/EiJ and C57BL/6 J.
Two of these crosses were previously characterized for cis-eQTLs and QTLs for various complex phenotypes by
genetic analysis of recombinant inbred (RI) strains. 5.4 %, 1.9 % and 1.5 % of genes assayed in forebrain of B6/
129SF1, B6/DBAF1, and B6/CASTF1 mice, respectively, showed differential allelic expression, indicative of cis-acting
alleles at these genes. Moreover, the majority of DAE QTLs were observed to be tissue-specific with only a small
fraction showing cis-effects in both tissues. Comparing DAE QTLs in F1 mice to cis-eQTLs previously mapped in RI
strains we observed that many of the cis-eQTLs were not confirmed by DAE. Additionally several novel DAE-QTLs
not identified as cis-eQTLs were identified suggesting that there are differences in sensitivity and specificity for QTL
detection between the two methodologies. Strain specific DAE QTLs in B6/DBAF1 mice were located in excess at
candidate genes for alcohol use disorders, seizures, and angiogenesis previously implicated by genetic linkage in
C57BL/6J × DBA/2JF2 mice or BXD RI strains.
Conclusions: Via a survey for differential allele expression in F1 mice, a substantial proportion of genes were found
to have alleles altering expression in cis-acting fashion. Comparing forebrain and kidney, many or most of these
alleles were tissue-specific in action. The identification of strain specific DAE QTLs, can assist in assessment of
candidate genes located within the large intervals associated with trait QTLs.
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Background
Gene expression is regulated by multi-layered genetic
and epigenetic mechanisms. Genetic variation can lead
to inter-individual variation in gene expression through
both cis- effects at genes and by trans-acting mecha-
nisms. Trans-acting factors may affect transcription of
target genes irrespective of genomic location, or modu-
late levels of transcripts derived from genes located on
either the paternally or maternally derived chromosome.
Trans-acting factors most obviously include DNA-
binding transcription factors [1], but also any of the
other diverse molecular actors, microRNA’s, ribosomal
proteins, rRNA’s and ions, that can alter transcription, or
RNA processing, or RNA stability, or RNA translation.
Cis-regulatory elements modulating transcript expres-
sion are usually located nearby or within genes, but at
the minimum are on the same chromosome. Genetic
variations in cis-regulatory elements located anywhere
upstream, downstream, within introns, and as well as in
the 5’ and 3’ un-translated regions of genes, and even at
considerable distances from genes, can alter transcrip-
tion, mRNA stability, mRNA processing efficiency, or
mRNA isoform expression [2]. The importance of gen-
omic elements that regulate gene expression was
highlighted in a series of studies arising from the EN-
CODE project, suggesting that a significant proportion of
the human genome might regulate gene expression [3].
Genetic variation altering gene expression plays a crit-
ical role in health and disease. For example, regulatory
variants located 14 kb upstream and 8 kb downstream
from the lactase gene lead to persistence of expression
of the lactase gene in adulthood, and lactose intolerance
[4]. In behavioral genetics, a polymorphism in the imme-
diate 5’ upstream region of the neuropeptide Y gene
(NPY) alters transcription of this gene and, through the
role of this neuropeptide in stress response and emotion,
alters susceptibility to stress and pain [5]. Variants affect-
ing transcript levels may be particularly important in
neurogenic disorders [6, 7] including schizophrenia for
which some 108 genes were recently implicated by gen-
ome wide association [8], but only a few functional loci
have actually been identified [9]. Genome-wide association
studies of other complex disorders have implicated many
chromosomal regions. However, the causal functional gen-
etic variants, many of which appear to be located far from
any known gene, remain largely unknown.
Despite the importance of identifying cis-acting func-
tional loci that alter gene expression, progress has been
limited and achieved largely on a gene-by-gene basis.
Genetic methods associating SNP and SNV (single nu-
cleotide variant) alleles to RNA levels measured by
microarray or RNA-Seq have been used to identify cis
and trans-eQTLs, but this approach only infers causality
for any particular variant by association [10]. Although a
large number of putative cis- and trans- expression
quantitative trait loci (eQTLs) have been located in hu-
man and rodents by genetic methods, most have not
been validated at the level of molecular function.
Differential allele expression (DAE) analysis by RNA-
Seq is a genomic molecular approach that can overcome
many of the main biological limitations in detection of
cis-acting loci. DAE requires the presence of a heterozy-
gous reporter variant in the transcript. DAE QTLs are in
this regard cis-eQTLs. DAE can confirm cis-acting
eQTLs identified by genetic approaches but can also be
an exquisitely sensitive and potentially more accurate
tool for detection. By measuring the differential expres-
sion of heterozygous reporter alleles within the same
cell, tissue and individual, the differential actions of cis
alleles in proximity to the reporter locus are observed in
the same context. The relative expression of transcribed
alleles at heterozygous reporter loci is measured. Using
reciprocal crosses, DAE can also detect parental imprint-
ing of genes due to epigenetic events including DNA
methylation, histone modification, non-coding RNAs
(ncRNAs) and chromatin organization that are mechan-
istic in the mono-allelic expression of autosomal genes
[6]. DAE has previously been used in F1 mice to identify
strain -specific DAE QTLs and effects of genomic im-
printing. Several studies have reported allelic imbalance
in F1 mice using RNA-Seq [11–19]. Most of these stud-
ies have focused on parent-of-origin effects, as seen for
imprinted genes [13–16, 18, 19]. Inconsistencies that
have been observed in the studies arose in part because
of technical differences [13, 16]. However, two types of
parental imprinting patterns have been reported via
DAE: a classical imprinted pattern in which there is full
allelic silencing and allelic imbalance [11–13, 16, 19].
Reports using DAE to detect strain-specific DAE QTLs
have been limited. Analysis of expression in liver of recip-
rocal F1 crosses between C57BL/6J and CAST/EiJ [12]
and crosses between C57BL/6J and DBA/2J [17] found
that approximately 14 % of assayable genes, 1,391/10,090
[12] and 284/2256 [17], had RNA cis-eQTLs in both
crosses even though the number of assayable genes, which
is to say expressed genes with SNVs in transcripts, varied
between the two studies. RNA-Seq DAE performed on
brain from three different reciprocal F1 mouse crosses in-
cluding the wild derived inbred strains, CAST/EiJ, PWK/
PhJ, and WSB/EiJ suggested that greater than 80 % of
assayable genes have DAE QTLs, with approximately 64 %
of these being detectable in any one of the three reciprocal
crosses [11]. This latter study suggested that the great ma-
jority of genes have a cis-acting functional locus modulat-
ing RNA expression, but the findings between studies are
clearly discrepant, and an intent of our study was to
distinguish between these two highly disparate estimates
of the abundance of cis-acting loci.
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We used RNA-Seq to identify DAE QTLs that may
alter behavior or other genetically influenced pheno-
types. We analyzed transcriptomes of two tissues (fore-
brain and kidney) of F1 mice derived from reciprocal
crosses between the C57BL/6J (B6) inbred mouse strain
and strains with which it is known to display distinct be-
havioral characteristics, 129S1/SvlmJ (129S) and DBA/2J
(DBA), as well as the more genetically divergent wild-
derived inbred strain, CAST/EiJ (CAST). DAE is assay-
able only for genes whose transcripts contain SNVs that
differentiate the two parental strains. In the absence of
cis-acting alleles or imprinted elements, genes transmit-
ted from either parent will be equally expressed. DAE
QTLs were validated by direct Sanger sequencing of RT-
PCR products, by RT-qPCR quantitation of mRNA levels
in parental strains, and by the ability of DAE to reliably
detect known imprinted loci and X chromosome-
encoded genes, in the latter male F1 mice. Using RNA-
Seq DAE we estimated the fraction of transcripts assay-
able for cis-eQTLs within these crosses and the number
of cis-eQTLs active in forebrain and kidney. We also
compared the sensitivity and specificity of DAE analysis
for the identification of cis-acting loci modifying tran-
script levels to eQTLs identified in the relevant mouse
strains and explored the relevance of DAE QTLs to
genes implicated in complex traits by genetic linkage
analyses in these strains.
Results
Genome-wide identification of DAE QTLs in forebrain and
kidney of F1 mice by RNA-Seq
Reciprocal crosses were made between C57BL/6J (B6)
and three other inbred strains: 129S1/SvlmJ (129S),
DBA/2J (DBA), and CAST/EiJ (CAST). PolyA+mRNA
was prepared from forebrain and kidney of F1 mice gen-
erated from these crosses and mRNA was pooled from
six individual F1 mice for each transcriptome library. In
the twelve sequencing analyses between 17.8 and 45.4
million sequence fragments, corresponding to 0.64–1.75
Gb, were mapped (Additional file 1: Table S1). Mapped
reads were analyzed for sequence variation in order to
determine whether either parental allele was preferen-
tially expressed. When the B6 reference sequence
(NCBI37/mm9) was used to map F1 RNA-Seq reads, al-
lelic mapping bias was detected, evidenced by the ap-
pearance of an excess of B6 allele specific reads in both
sides of any reciprocal cross. We also observed the exist-
ence of reference bias by mapping sequence reads to a
reference in which other strain specific variants were in-
troduced. Reference bias was eliminated by mapping
data to both parental reference genomes and averaging
results; the equivalent of mapping to a haplotypically ac-
curate heterozygous reference sequence (Additional file
2: Figure S1). Strain-specific alleles were validated
through exome sequencing of the parental mouse strains
and by comparison to the Sanger mouse genome re-
source (The VCF file 20111102-snps-all.annotated.vcf.gz
was downloaded from ftp://ftp-mouse.sanger.ac.uk/
REL-1105) to ensure that only genuine SNVs were inter-
rogated (Additional file 1: Table S2).
DAE was analyzed in forebrain and kidney for the
three reciprocal crosses. Only SNVs with read counts ≥8
were included, this being the threshold at which DAE
was consistently detected for known maternal and pater-
nally imprinted genes (Additional file 1: Table S3). Dif-
ferentially allelic expressed transcripts were observed in
both tissues for all three reciprocal crosses (Additional
file 2: Figure S2). In each instance there was a similar ra-
tio of over-represented strain-specific alleles in all ana-
lyses, indicating that reference bias was successfully
eliminated. The number of genes assayed for DAE varied
depending upon the number of strain-specific SNVs de-
tectable and the tissue. Using these criteria, approxi-
mately 3,000–5000 genes were assayable for DAE in
forebrain and 2,500 – 4,500 genes in kidney. Using a
FDR cutoff of p ≤ 0.05 and requiring the same direction
of expression in each F1 cross, 3.2 – 9.7 % of assayed
genes in forebrain showed significant allelic imbalance in
expression. Although kidney had fewer assayable genes
for DAE analysis than forebrain, it had higher propor-
tion of genes with evidence of DAE QTLs (7.6–19.5 %)
(Additional file 2: Figure S2).
Identification of DAE QTLs is enhanced by observa-
tion of consistency of DAE in reciprocal F1 crosses.
When DAE effects are not consistent in reciprocal
crosses, this can identify genes imprinted according to
parental origin. Using DAE patterns we were able to
identify imprinted genes and distinguish these from
strain-specific DAE QTLs. The numbers of genes exhi-
biting DAE varied between the different F1 crosses, and
between tissues (Fig. 1): 5.4 % (200/3,722), 1.9 % (51/
2,669) and 1.5 % (61/4,171) of expressed genes showed
DAE in forebrain in B6/129SF1(B6129SF1 and
129SB6F1), B6/DBAF1(B6DBAF1 and DBAB6F1), and
B6/CASTF1(B6CASTF1 and CASTB6F1) reciprocal
crosses respectively, and for 11.5 % (322/2,794), 9.1 %
(203/2,236) and 5.0 % (165/3,320) of expressed genes in
kidney in the B6/129SF1, B6/DBAF1, and B6/CASTF1
reciprocal crosses respectively.
The overlap in genes showing significant DAE in both
reciprocal crosses was greater than expected by chance
(Additional file 1: Table S4). Surprisingly, after FDR cor-
rection the number of DAE QTLs was smallest in B6/
CAST F1 mice, despite the fact that there are a larger
number of informative SNVs in this cross than for the
other crosses. This observation is possibly explained in a
comparison of the forebrain data from B6/CASTF1 with
B6/129SF1 which showed that most of the potentially
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informative SNVs for the B6/CAST F1 mice were lo-
cated in transcripts with low sequence read number
even though the B6/CAST F1 mice had higher
mapped read counts than the other crosses
(Additional file 1: Table S1). Analysis of DAE using a
preselected set of transcribed regions (or “genes”)
could potentially implicate additional B6/CAST loci
as having DAE QTLs. However, our pipeline was de-
signed to test DAE in transcripts regardless of
whether the transcript was associated with an anno-
tated gene, and in keeping with the potential, and at
times already demonstrated, functional significance of
some non-coding RNAs.
Validation for strain-specific and parental allele specific
DAE-QTLs in the forebrain
We tested the ability of our RNA-Seq based pipeline to
reliably detect DAE QTLs in multiple ways. Because
analyses were performed on male F1 mice, only the ma-
ternal allele should be detectable in transcripts derived
from the X chromosome, and this was confirmed for al-
most all the DAE assayable X-linked genes in all the F1
crosses (Additional file 2: Figure S3). Next, DAE results
for 20 randomly selected genes with SNVs showing sig-
nificant DAE in forebrain (FDR p-value ≤ 0.05) and 15
genes with SNVs showing no DAE, were validated in the
individual F1 mice originally pooled for RNA-Seq by
Fig. 1 Distribution of DAE genes with strain specific imbalance and imprinted genes in forebrain and kidney. Volcano plots depict B6 allele read
frequencies (0–1) against FDR corrected (−log10) P values for significance of allelic imbalance for (a) B6/129SF1, (b) B6/CASTF1, and (c) B6/DBAF1
reciprocal crosses in forebrain and kidney. Pie charts depict relative frequencies of over represented parental alleles and imprinted genes. The
number of genes with cis-loci altering transcript expression as detected by RNA-Seq DAE (DAE QTLs) observed in both reciprocal crosses is shown
below the tissue, with the cross in (parentheses)
Yeo et al. BMC Genomics  (2016) 17:620 Page 4 of 15
quantitative Sanger sequencing using cDNA. Sequence
from genomic DNA of the same F1 mice was used to
control and correct for any bias in allelic quantitation.
Findings from the quantitative Sanger sequencing
showed excellent correlation with RNA-Seq allelic ex-
pression imbalance (or the lack thereof ) for all 35 genes
analyzed (Additional file 2: Figure S4B). The validity of
RNA-Seq to identify genuine DAE QTLs was further
demonstrated by the detection of multiple previously
identified imprinted genes in forebrain [13, 20–23].
These included 16 imprinted genes (Zrsr1, Nap1l5,
Calm1, Snrpn, Peg3, Ndn, Dlk1, H13, Zdbf2, Sgce, Peg10,
Usp29, Inpp5f, Rasgrf1, Copg2 and Impact) and 7
imprinted non-coding RNAs (Apeg3, Rian, Snord64,
Meg3, D7Ertd715e, Peg13 and C230091D08Rik). DAE of
several of these imprinted genes and non-coding RNAs
was confirmed by quantitative Sanger sequencing (Add-
itional file 2: Figure S5). We uncovered at least one in-
stance of a gene, Zim3, that has been reported as
maternally imprinted in mouse testis [20] but which
shows strong DAE in forebrain where only the 129S- de-
rived transcript is expressed in either reciprocal F1. Fur-
ther, in the parental strains, 129S mice express Zim3 at
levels 6-fold higher than B6 mice (Additional file 2: Fig-
ure S8). The DAE in reciprocal F1 mice and the differing
levels of Zim3 expression in the parental strain together
suggest that, at least in forebrain, Zim3 expression is not
regulated by imprinting, but by cis-acting functional ele-
ments that vary between B6 and 129S mice. Direct
Sanger sequencing of Zim3 cDNA from the F1 animals
also indicated the presence of two alternatively spliced
transcripts, however individual F1 mice only expressed
one of these two isoforms, the expressed transcript al-
ways being derived from the 129S allele suggesting a
complex regulation of this locus.
For comparison to the genetic approach for detecting
eQTLs of measuring RNA levels in RI strains and to fur-
ther confirm DAE QTLs, we measured transcript levels
in parental strains for 10 genes that exhibited DAE
QTLs in the F1 mice. Expression levels were normalized
to the expression in B6 mice and the ratios of expression
levels compared to the RNA-Seq and quantitative Sanger
sequencing allelic imbalance ratios observed in the F1
mice. There was good correlation between the relative
parental expression levels and the ratio of allelic expres-
sion observed in the F1 mice. These multi-level results,
including consistent allelic imbalance in the two recipro-
cal F1 strains identified by RNA-Seq, replication of the
allelic ratios by quantitative Sanger sequencing, and the
coherent differential gene expression in the parental
strains not only confirm strain-specific DAE QTLs, but
also demonstrate the value of using RNA-Seq for
genome-wide identification of cis-eQTLs altering gene
transcript levels (Additional file 2: Figure S4C).
Tissue-specific and shared DAE QTLs between forebrain
and kidney
The ratios of genes in which either the B6 allele or
alternative allele was preferentially expressed was
similar in all three reciprocal crosses, for both fore-
brain and kidney. DAE QTLs can be identified based
on consistency of DAE in the reciprocal crosses, by
extent of differential expression, and by level of statis-
tical significance, or by a combination of these pa-
rameters. We have in effect done this by pruning the
genes analyzed for DAE by level of representation in
the sequencing, prior to applying statistical testing,
and by use of reciprocal crosses.
Tissue-specific DAE was common, but in line with
previous lower estimates. Only a small proportion of
genes showed conservation of DAE pattern between
forebrain and kidney even though the same combina-
tions of DNA control elements will be present to regu-
late gene expression across different forebrain and
kidney samples. Tissue-specific cellular function is
reflected in part by different patterns of gene expression
between tissue types. Analysis of expressed genes with
SNVs detected in both forebrain and kidney in both re-
ciprocal crossed F1 mice identified 2,173 genes in B6/
129SF1, 1,511 genes in B6/DBAF1, and 1,951 genes in
B6/CASTF1. Within this subset of genes 11.9 %, 8.5 %,
and 5.0 % showed forebrain DAE QTLs in B6/129S F1,
B6/DBA F1 and B6/CAST F1, respectively, but only a
small proportion of DAE genes showed DAE in both
forebrain and kidney: 2.4 % in B6/129SF1, 0.7 % in B6/
DBAF1, and 0.3 % in B6/CASTF1 (Fig. 2a). Also, we ob-
served that for the subset of genes expressed in both
kidney and forebrain that more genes showed DAE in
kidney than in forebrain (Fig. 2b). Moreover, in forebrain
3 genes, Acadm, Aldh7a1, and Dci, showing preferential
BL6 allelic expression showed 129S-allelic preference in
kidney in both F1 crosses, suggesting that cis-acting loci
at these genes were regulated by tissue specific trans-
factors. These tissue-specific DAE findings are unlikely
to be significantly confounded due to variation in detec-
tion power, which is affected by both tissue-specific ex-
pression level and sequence coverage, because our
comparison only included genes detected at ≥ 8 reads in
both tissues, and which showed similar allelic preference
for a tissue in both reciprocal crosses. Additionally no
bias was observed towards tissue where more sequen-
cing read counts are obtained as would be expected if
expression level was influencing the results. These
data show that the majority of co-expressed genes in
both kidney and forebrain were expressed with a pref-
erence for a specific allele in only a single tissue type
illustrating the importance of tissue-specific factors in
transcriptional regulation, and RNA processing and
stability.
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Important genes in neural functions and behavior show
strain-specific differential allelic patterns in the forebrain
Several genes known to play critical roles in neural func-
tions and behavior exhibited DAE QTLs in forebrain of
B6/129SF1 mice. Gabra2 encodes the gamma-
aminobutyric acid (GABA) receptor α-2 subunit. GABA
receptors are ligand-gated chloride ion channels that
mediate GABA inhibitory neural transmission and that
have been shown to influence alcohol and other addict-
ive substance use. A negative correlation between oral
morphine consumption and Gabra2 expression was ob-
served in inbred mouse strains [24, 25]. In B6/129S F1
mice, the 129S allele is expressed at levels 4-fold higher
than the B6 allele in both reciprocal crosses (Fig. 3). This
finding is consistent with the previously observed behav-
ioral differences between the strains, and with the obser-
vation that Gabra2 expression differs between C57BL/6J
and 129S1/SvlmJ strains. This could be a trans-regula-
tory effect, but our data suggests that the observed
strain-specific differences in Gabra2 expression arise
due to the presence of cis-acting variants at or near the
Gabra2 gene.
Variation at the Gas5 gene (growth arrest specific 5)
has been associated with levels of aggressive behavior in
mice. This non-coding RNA was shown to be expressed
at levels 8-fold higher in the brains of highly aggressive
mouse strains than in less aggressive strains [26]. B6
mice have been reported to exhibit higher levels of ag-
gressive behavior than 129S mice [27]. Our data showed
both higher levels of Gas5 expression in forebrain of B6
compared to 129S mice, and that the B6 allele is prefer-
entially expressed in the forebrain of both reciprocal B6/
129S F1 crosses (Fig. 3). This suggests that a cis-element
in B6 allele promotes stronger transcription of the Gas5
gene. However, an alternative explanation is that a dele-
tion (chr1:162,966,110) in the Gas5 gene of 129S mice
may lower the stability of the 129S-derived transcript,
which calls attention to the need to consider non-
transcriptional mechanisms for eQTLs.
Genetic association with phenotype (QTLs) in crosses
between inbred strains of mice and DAE QTLs in F1 mice
as evidences of QTLs
Genomic loci modulating several behavioral phenotypes
have been mapped using genetic markers in crosses of
inbred mouse strains and in recombinant inbred (RI)
lines such as the BXD lines and more recently the Diver-
sity Outbred (DO) crosses. Mapping these behavioral
quantitative trait loci (QTLs) has identified genomic re-
gions containing multiple candidate genes for a variety
of behaviors, including ethanol-related phenotypes [28,
29], cocaine-related phenotypes [30], and seizure suscep-
tibility [31]. A survey of the Mouse Genome Informatics
(MGI) database identified 131 QTLs covering 45 differ-
ent phenotypes (response to alcohol, morphine, cocaine,
or methamphetamine, and other neurobehavioral pheno-
types including seizures, sleep, and circadian rhythm).
The QTL findings distinguishing B6 mice and DBA mice
implicate some 415 candidate genes in crosses involving
the B6 and DBA strains (Additional file 1: Table S5). Of
these 415 candidate genes 91 were assayable for DAE in
forebrain, using our stringent criteria, and 61 were
assayable in kidney. The remainder either lacked the
prerequisite genetic variation for assay, or was not
expressed at a sufficient level. Four of the 91 candidate
forebrain genes were DAE QTLs in the B6/DBA F1
mouse forebrain: Darc (duffy antigen receptor for che-
mokines), Kifap3 (kinesin-associated protein 3), Atp1b1
(sodium/potassium-transporting ATPase subunit beta-1
and Ndn (necdin), indicative of the presence of cis-
acting regulatory alleles different the parental strains
(Additional file 1: Table S6). Atp1b1 showed elevated
Fig. 2 Tissue specific and non-tissue specific DAE QTLs in forebrain and kidney. a Tissue specific and non-tissue specific DAE QTLs. The X-axis indicates
the number of co-expressed DAE-assayable genes in forebrain and kidney of each reciprocal F1 cross. Y-axis is the ratio of tissue specific DAE QTL
genes and non-tissue specific DAE QTL genes in all genes that are expressed in both forebrain and kidney, and that have SNVs, making them assayable
for DAE in both tissues. b Kidney, forebrain, and non-tissue specific DAE QTLs. Y axis indicates number of DAE QTLs
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levels of the DBA derived transcript in both forebrain
and kidney (Additional file 2: Figure S6). The fraction
of QTL-implicated candidate genes exhibiting DAE
was higher than would be expected by chance. In
brain, 4.4 % (4/91) of the candidate genes were DAE QTLs
as compared to 1.9 % (51/2669) overall (p = 0.0008). Simi-
larly, in kidney, 21.3 % (13/61) of the QTL-implicated
candidate gene genes were DAE QTLs versus 9.1 % (203/
2236) overall (p = 0.019).
Several of the genes that we find differentially
expressed in mouse forebrain have been previously im-
plicated in alcohol preference via alcohol QTLs and
shown to differ in expression in B6 mice as compared to
other strains via conventional transcript measures. DAE
Fig. 3 DAE QTLs and differential gene expression in the forebrain of B6/129SF1 mice and parental strains. a The 129S Gabra2 allele was over-
represented in reciprocal crosses when assayed either by RNA-Seq or by Sanger Sequencing. b qPCR in forebrain of the parental B6 and 129S
strains shows that Gabra2 is more highly expressed in the 129S strain. These data suggest the presence of a cis-acting regulatory element at
Gabra2 that is allelically variable between the two strains. c The B6 Gas5 allele was over-represented in reciprocal crosses when assayed either by
RNA-Seq or by Sanger Sequencing. a, c In RNA-Seq data, total numbers of reads of all SNVs in a gene were added up and then significance of
DAE in the total number of reads was assessed by a binomial test. False Discovery Rate (FDR) adjusted p-values were obtained by the Benjamini-
Hochberg method. The allele signals from the Sanger cDNA sequencing results were normalized using the allele-specific peak ratios from the
Sanger gDNA sequencing. To test if the B6 allele and 129S allele were equally expressed, Sanger sequencing data were evaluated by a one-tailed
t-test with values of B6 allele area/(B6 allele area + 129S allele area). **P < 0.005 and *P < 0.05 (d) qPCR analysis of forebrain of the parental B6 and
129S strains showed that Gas5 is more highly expressed in the B6 strain. (B,D) Data of qPCR are the means ± SEM of 4 or 5 mice of each 129S1/
SvlmJ and C57BL/6 J. **P < 0.005 and *P < 0.05 by a two-tailed t-test. These data suggest the presence of a cis-acting regulatory element at Gas5
that is variable between the two strains, however (e) the presence of a 1 bp deletion in the 5’-UTR of 129S transcript may lead to transcript instability
resulting in the observed allelic expression imbalance in F1’s and difference in expression between parental strains, as discussed
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in B6/DBAF1 mice confirms previous findings that Darc,
Kifap3, Aldh9a1, Sc5d, Sdhc and Sorl1 are transcribed at
different levels in B6 and DBA brains between B6 and
DBA mice [28, 29], a difference arising due to the pres-
ence of cis-acting loci at these genes (Additional file 2:
Figure S6). 129S and DBA mice show lower alcohol pref-
erence compared to B6 mice [32–34], and we observe
that Darc, Sdhc, and Sc5d, all candidate genes at alcohol
related QTLs, have DAE QTLs in the forebrain and kid-
ney of both B6/DBA and B6/129S F1 mice.
Hdc (histidine decarboxylase), a candidate gene within
the Pbrgcsf1 QTL (peripheral blood stem cell response
to granulocyte colony stimulating factor 1) [35], has
been shown to differ in expression between inbred
mouse strains. Hdc protein levels and enzymatic activ-
ities of the DBA/2J mouse are approximately 10-fold
higher than in C57BL/6J but only in the kidney [36].
Consistent with these findings, we observed that the
DBA allele of Hdc is almost exclusively expressed in kid-
ney of B6/DBAF1 mice (Additional file 2: Figure S6) sug-
gesting the existence of a DBA specific, cis-acting
regulatory sequence variant.
However, most assayable candidate genes within the
identified QTLs for complex phenotypes did not show
DAE QTLs in B6/DBAF1 mice (Additional file 1: Table
S7) even though several of these genes previously were
flagged as showing higher or lower transcript levels in
C57BL/6J mice compared to DBA/2J mice [28]. This
may suggest a difference in methodological precision of
DAE versus measures of transcript level, or more intri-
guingly that the differences in transcript levels were
caused by trans-acting factors, and even though the
genes were located within behavioral QTLs. The fact
that a gene exhibiting altered transcript levels is local-
ized to a QTL does not necessarily mean that the se-
quence variant altering level of the transcript is local to
the gene. For example, Syn3 was identified as a candi-
date gene associated with a reversal-learning phenotype
in the BXD RI strains based on its being one of five
genes under a behavioral QTL peak, and because its
level of expression correlated with the behavioral pheno-
type in BxD strains [37]. However, our data reveal no
DAE for Syn3 in the B6/DBA F1 mice (Additional file 2:
Figure S7), indicating that at least for this candidate gene
the difference in RNA expression which correlates with
the phenotype may not be due to a cis-acting regulatory
variant, but may arise through a trans mechanism or
may have been an artifact chance finding. Most likely,
many of the gene expression differences observed be-
tween strains and implicating genes that map to QTLs
are not due to the actions of cis-acting loci at these
genes. We note, however, that it is possible that an ac-
tion of a cis-locus to drive DAE might be observed in
other brain regions. DAE based on RNA-Seq of one
brain region, or even several, cannot rule out the exist-
ence of cis-acting loci operative in some region of the
brain or a particular cell. However, where a DAE QTL is
observed, it strongly points to the existence of such a
cis-locus. Although cis-effects will not be observed for
most genes within QTL intervals, using RNA-Seq in F1
animals we were able to observe cis-effects for candidate
genes related to alcohol, seizures, angiogenesis, and periph-
eral blood stem cell response (Additional file 1: Table S6).
Cis-eQTLs in RI and F2 databases vs DAE QTLs in F1 mice
Multiple expression quantitative trait loci (eQTLs) have
been identified by correlating genotype data with gene
expression in F2 crosses and RI strains. Using RNA-Seq
DAE we estimated the number of genes with eQTLs in
BXD RI strains that represent genuine cis-eQTLs using
the BXD eQTLs listed in GeneNetwork (www.genenet-
work.org). In GeneNetwork the BXD brain cis-eQTLs
are based on data from 29 BXD RI strains, collected
from three RNA-Seq datasets. The kidney cis-eQTLs in
this database are derived from 54 BXD RI lines collected
from three RNA micro array datasets. Out of the 26,378
autosomal genes listed in GeneNetwork, 17,698 and
16,222 were found as eQTLs in whole brain and kidney,
respectively (Fig. 4), and of which 1,959 in whole brain
and 2,347 in kidney are listed as cis-eQTLs. Only 1,464
genes in brain (74.7 %) and 1,933 in kidney (82.4 %)
were potentially assayable by DAE, and of these only 653
genes in brain and 870 genes in kidney were available to
observe in our B6/DBAF1 RNA-Seq. 45 of 51 DAE
QTLs in forebrain and 167 of 203 DAE QTLs in kidney
were listed as eQTLs. 17/653 assayable whole brain cis-
eQTLs and 117/870 assayable kidney cis-eQTLs were
confirmed by DAE QTLs. The rate of confirmation was
above random expectations (brain: p = 0.0003, kidney:
p = 0.001), the randomly expected overlap being only
5.3 and 16.2 genes in brain and kidney respectively,
as compared to 17 and 117 genes observed. However,
97 % (636/653) of assayable forebrain cis-eQTLs and
87 % (753/870) of assayable kidney cis-eQTLs could
not be confirmed by DAE. Overall, these data suggest
that cis-eQTL mapping, using a restricted number of
RI strains in which RNA levels are quantitated, has a
high false-positive rate. Additionally, 28 genes in fore-
brain and 50 genes in kidney showing DAE QTLs in
B6/DBAF1 mice had not been reported as cis-eQTLs
in BxD RI strains, and 6 imprinted genes,
C230091D08Rik, D7Ertd715e, Peg10, Peg13, Ragrf1,
and Zdbf2 were identified only as eQTLs but not as
cis-eQTLs, which suggests that cis-eQTL mapping in
restricted numbers of RI strains also has a lower sen-
sitivity to detect cis-acting regulatory elements than
DAE performed in a single reciprocal F1 cross. The
discrepancy between reported cis-eQTLs and our
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DAE cis-eQTLs could arise from several confounding
factors including lack of LD between cSNV reporters
and regulatory loci in DAE analysis, inadequate se-
quencing in DAE coverage leading to failure to detect
more subtle allelic differences, and as is likely import-
ant, false positive and false negative cis-eQTLs from
studies of small numbers of RI strains.
Discussion
Using RNA-Seq based transcriptome analysis, we per-
formed genome-wide DAE to identify cis- regulated
genes in the forebrain and the kidney of F1 mice gener-
ated through reciprocal crossing of C57BL/6J to one of
three other inbred strains: 129S1/SvlmJ, DBA/2J and
CAST/EiJ. 129S1/SvlmJ and DBA/2 J differ from C57BL/
6J in several phenotypic traits including alcohol
preference, anxiety behaviors, etc. [27, 33]. CAST/EiJ
carries a greater number of genetic variants compared to
the three inbred strains [38]. We used stringent filters to
identify cis- regulated genes in the F1 mice to reduce the
likelihood of false positive results, and even of the ex-
treme of assayability. These filters included independent
verification of SNVs from the Sanger database and ex-
ome sequencing of the parental inbred mice, cross- val-
idation of allelic expression in the two reciprocal F1
strains, and use of an FDR threshold ≤ 0.05. These mea-
sures allowed us to identify genes with strain-specific
and tissue-specific allelic expression and imprinted genes
with high accuracy, and in strong correlation with differ-
ential gene expression in the parental strains.
The DAE QTLs we identified showed several validat-
ing features. Firstly, they could be verified by several
Fig. 4 Comparison of DAE QTLs of B6/DBAF1 mice with autosomal cis-eQTLs of BxD RI mice. (a) forebrain and (b) kidney. BXD RNA-Seq data (green boxes)
showing (a) total number of detected genes, (b) total number of genes, at cis-eQTLs, (c) number of DAE assayable genes at cis-eQTLs, (d) number of genes,
at cis-eQTLs, overlapping with DAE QTLs in F1 RNA-Seq, (e) number of genes, at cis-eQTLs, which were not confirmed as DAE QTLs. Data from DAE QTLs
detected by B6/DBAF1 RNA-Seq (brown boxes) showing (a) total number of detected genes, (b) number of genes detected in BXD and F1 RNA-Seq, (c)
number of DAE QTLs, (d) number of DAE QTLs, which were not detected as cis-eQTLs. The yellow box shows the number of genes identified in both cis-
eQTLs and DAE QTL analyses. The degree of overlap between the two approaches is significant in both forebrain (p= 0.0003) and kidney (p= 0.001)
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factors such as consistent maternal-allelic expression of
X-linked genes in F1 male mice (Additional file 2: Figure
S3) and highly consistent correlation (r = 0.89, p = 5.4E-
15) between Sanger sequencing and RNA-Seq. More-
over, we also observed that genes with strain-specific al-
lelic expression in F1 mice were highly differentially
expressed between the parental inbred strains with sig-
nificant correlations between the qPCR results in the in-
bred strains and DAE results in F1 mice (r = 0.7, P = 0.014)
(Additional file 2: Figure S4). Those results ensure that the
observed DAE QTLs in F1 mice are represent authentic
DAE and the action of cis-acting loci.
An important piece of evidence supporting the sensi-
tivity and specificity of DAE QTLs was the successful
detection of the imprinted genes exhibiting allele-
specific transcription depending on maternal or paternal
origin [39]. The number of imprinted genes expressed in
brain remains uncertain, but our detection of 16
imprinted genes in B6/CASTF1 forebrain, is in line with
a recent analysis [16], indicating that parentally
imprinted genes number in the dozens, rather than hun-
dreds, or even thousands reported elsewhere [13]. An
important methodological caveat is that we analyzed ex-
pression in forebrain (as well as kidney), rather than in
whole brain which is where the data reporting the much
larger number of imprinted genes was derived. Of the 16
imprinted genes identified in our study, 13 were previ-
ously shown to be imprinted by DeVeale and colleagues
(Additional file 1: Table S8). The smaller number of
imprinted genes detected in our study reflects technical
factors including sequencing coverage and the highly
stringent filters used for SNV inclusion to reduce false
positives, as also led to a lower number of DAE assay-
able genes. It should be noted that earlier studies also
identified fewer imprinted genes in adult prefrontal cor-
tex and preoptic area than were found in the developing
E15 brain. Because only 4,171 genes were assayable for
DAE in our study, the total number of imprinted genes
may be higher, but is unlikely to number in the thou-
sands. We also detected imprinting of 4 non-coding
transcripts, suggesting that other noncoding transcripts
not assayable for DAE in our study might also be
imprinted. It has recently been reported that random
mono allelic expression (RMAE) is widespread in lym-
phoblastoid cell lines derived from F1 mice generated by
mating a129S1/SvlmJ dam to a Cast/EiJ sire, and that
approximately 10 % of assessed genes showed DAE [40].
Surprisingly, although each clone of lymphoblastoid cell
lines had the same genetic background, each clone had
different patterns of differential allele expression across
the same genes [40]. It has been hypothesized that vari-
ous factors in cell culture conditions might drive this ob-
served increase in variability in DAE [41, 42]. Despite
the fact that forebrain consists of a mixture of different
cell types (e.g., cholinergic, GABAergic neurons), we de-
tected consistent patterns of DAE by RNA-Seq and
Sanger sequencing using the forebrain of the same six
F1 mice. This indicates that strain-specific DAE QTLs
are consistent among F1 mice with the same genetic
background.
Thirdly, we observed more tissue-specific DAE QTLs
than non-tissue specific DAE QTLs (Fig. 2). This sug-
gests that each tissue has tissue specific trans-factors in-
fluencing allelic expression, which shows B6 allele
specific, alternative allele specific or bi-allelic manner in
those F1 mice. These findings point to complexities of
regulatory networks that affect tissue-specific expression
at both gene and allelic levels.
Our strain-specific DAE QTLs showed correlations
with strain-specific differences in gene expression that
have previously been to be associated with strain-
specific phenotypes. Genetic variations at Gas5 and
Gabra2 are associated with the more aggressive behav-
iors of C57BL/6J and with the lower oral morphine con-
sumption in 129S/SvlmJ compared to C57BL/6J,
respectively [24–26]. Although the differences in behav-
iors between C57BL/6J and 129S1/SvlmJ can be corre-
lated with differential gene expression between the
strains [24–26], our F1 RNA-Seq data revealed that dif-
ferential gene expression arose due to cis-acting genetic
variants at those loci (Fig. 3).
Understanding the genetic basis of phenotypic vari-
ation is crucial to a number of questions in behavioral
ecology. Many genes may influence a behavior, and
among there it is important to identify both coding se-
quence and regulatory variants. Of the genes in pheno-
typic QTLs that were assayable by DAE, 4/91 in
forebrain and 13/61 in kidney actually were DAE eQTLs,
representing candidate cis-acting loci for the phenotypes.
Failure to detect a DAE QTLs in F1 mice does not, how-
ever, mean that a cis eQTL is not present, for the reason
of sequencing coverage or R2 to the DAE SNVs, or cell
or tissue source of the RNA. Obviously, the molecular
mechanism that gives rise to the behavioral QTL might
not be related to RNA expression levels (Additional file
1: Table S5). However, our RNA-Seq DAE analysis did
reveal that several candidate genes within QTLs associ-
ated with alcohol-drinking, seizure, granular brain le-
sions, peripheral blood stem cell response to G-CSF1
and kidney activity (Additional file 1: Table S6) were reg-
ulated by cis-acting loci. For example, Darc, Sdhc, and
Sc5d, candidate genes, which lie within alcohol-drinking
QTLs, consistently showed DAE in both B6/DBAF1
mice and B6/129SF1 mice. Because DBA/2J mice and
129S1/SvlmJ mice show lower alcohol preference com-
pared to C57BL/6J mice, DAE of those candidate genes
could potentially explain the phenotypic trait differences
between the strains. The correlation between DAE in
Yeo et al. BMC Genomics  (2016) 17:620 Page 10 of 15
the F1 mice and behavioral differences in their parental
strains not only validate our DAE findings, which were
also consistent with the differential gene expression in
the parental strains, but also suggest the value of
genome-wide DAE to uncover genetic mechanisms
modulating gene expression and heritable phenotypes.
DAE analysis may potentially provide more direct evi-
dence of cis-regulation of genes than is provided by cis-
eQTLs. DAE loci detected by RNA-Seq in B6/DBAF1
mice and cis-eQTLs (GeneNetwork) using BXD recom-
binant- inbred mice (RI) are generated with the similar
aim of identifying of cis-acting functional loci. The prac-
tical consequence is that genetic and molecular methods
can be used to cross-validate each other. Emphasizing
the potential for the integration of the DAE QTLs with
eQTLs from BXD recombinant-inbred mice (RI) (Gene-
Network), a comparison observed DAE loci in the B6/
DBAF1 with BXD RI cis-eQTLs revealed significant
overlap of findings in both forebrain (P = 0.0003) and
kidney (P = 0.001) (Fig. 4), including several genes en-
coding GABA(A) receptor subunits. The B6 alleles of
both Gabrg2 and Gabra1 were over-expressed compared
to the DBA alleles [25, 43]. However, many assayable
and previously listed cis-eQTLs could not be verified by
DAE; 97 % (636/653 cis-eQTLs) in brain and 87 % (753/
870 cis-eQTLs) in kidney. Focusing effort on genes that
represent true-positives for functional cis-acting loci will
hopefully lead to more rapid identification of causal se-
quence variants, and mechanisms by which these vari-
ants modulate phenotypes. It can also improve the
power of gene network analysis, by identifying nodal
genes whose differential expression is driven by cis-act-
ing alleles, and that in trans-fashion may be driving
expression of other genes within functional networks
[44, 45]. In this regard, cis-eQTL mapping in RI strains
did not detect certain genes with DAE QTLs, inclusion
of which might strengthen gene network analyses. 28
DAE QTL genes in forebrain and 50 DAE QTL genes in
kidney were not detected as cis-eQTLs even though
these genes were annotated as eQTLs in the GeneNet-
work eQTL dataset. Among the same categories of genes
evaluated (assayable) by both methods, there are several
potential explanations for mismatches between RI cis-
eQTLs and DAE QTLs detected in F1 mice. These rea-
sons include several methodological nuances in DAE:
level of coverage and whether the reporter SNV is in
high LD (r2) with the cis-locus altering expression. For
cis-eQTLs derived from RI strains, a well-recognized
limitation is restricted number of strains. Further, par-
ticular circumstances and criteria, by which RI eQTLs
were generated, and complexity of genetic background
(trans-effect) can mask cis-eQTLs.
RI strains have been an important resource for investi-
gation and genetic mapping of Mendelian and quantitative
traits in the mouse over the past several decades [46]. The
RI panels provide numerous advantages, including the
ability to study many animals of the same genotype. The
additive genetic variance in a panel of RI strains is twice
that of a corresponding F2 intercross for the same trait, a
feature that increases the effective power to map subtle
polygenic traits. Using RI strains, it is possible to reduce
both environmental and technical sources of variance,
leading to the detection of variants altering function, in-
cluding gene expression [47]. However, the most notice-
able disadvantage of RI strains has been the modest
numbers of strains available per RI set, limiting their
power to detect cis-eQTLs [48, 49]. Estimates of the effect
size of QTLs identified in these RI panels are usually both
noisy and upwardly biased (overestimated). One solution
to this problem is to increase the size of RI strain panels
[50]. However this requires significant resources and time
for breeding and phenotyping. It does not eliminate the
problem of trans-acting factors that may obscure cis-
eQTLs or create false positives. The main advantages of
DAE over eQTL mapping are the reduced number of ani-
mals required for the identification of cis-acting functional
loci, and because the analyses are performed in F1 animals
no recombination between chromosomes of the parental
strains will have occurred, allowing the direct determin-
ation of the presence of cis-acting regulatory elements.
DAE analysis in F1 inbred mice relies on the distribution
of ratios of allele specific expression within each individ-
ual. DAE in F1 animals is readily adaptable to crosses
made between RI strains, or between the parental strains,
enabling the allele-specific effects on expression found by
DAE in F1’s to be integrated with RI-based QTLs for be-
havior and other complex phenotypes.
Although DAE is an important addition to techniques
for the identification of cis-acting regulatory elements, sev-
eral limitations make it a technique that is complimentary
to existing approaches such as eQTL mapping, rather than
a universal method for identifying cis-acting alleles or im-
printing. The primary limitation of DAE is that it requires
the presence of at least one informative transcribed SNP.
In outbred populations and for studies in humans this will
often not be a problem. Additionally, it is also helpful, but
not absolutely required for the reporter locus in strong LD
with the functional cis-acting element. In order to take full
advantage of DAE in human samples it is important that
phase is known for all variants within a region. Unlike
eQTL mapping, DAE directly identifies the presence of a
cis-acting regulatory element, but like eQTL mapping,
DAE does not directly identify the elements themselves
that are acting to alter gene expression.
When adequately controlled for mapping bias, and
other technical problems that limit assayability, DAE in
F1 mice shows a high rate of specificity for detecting cis-
acting loci, and the precision of the method, based as it
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is on transcript fragment counting, appears high. Our
study using three different reciprocal F1 crosses shows
that DAE is consistently observed in the same genomic
background regardless of parental origin, unless there is
imprinting. Intriguingly, pointing to cell-specific action,
most DAE is not conserved between forebrain, an ecto-
dermal derived tissue, and kidney, mesodermal derived
tissue. Further study is required to truly understand how
DAE QTLs in brain may be linked to behavioral pheno-
types, including alcohol and drug responses and levels of
anxiety that have been shown to vary among the inbred
mouse strains we studied.
Conclusions
Inbred mouse strains display differences in behavior,
drug preference, and responses to alcohol. These strain
differences are largely attributable to the genetic differ-
ences between them, including cis-acting elements that
alter gene expression. Previous studies reported genetic
variants associated with various phenotypes and differ-
ential gene expression through behavioral QTLs and cis-
eQTLs, the validity and molecular mechanism remain
further identification. Here, taking advantage of strain-
specific genetic variation, we applied RNA-Seq in the re-
ciprocally crossed F1 mice, to measure relative expres-
sion of alleles at heterozygous loci for differential allele
expression (DAE) indicative of strain specific cis-acting
loci altering RNA expression. We found that globally
about 2 % of genes assayed in forebrain were regulated
by cis-acting loci and most of the DAE genes showed tis-
sue specificity. Also, through comparing our data with
previous phenotype QTLs and cis-eQTLs, we have built
on the literature showing DAE analysis is valuable in
identifying and confirming cis-acting regulated genes
that have been associated with specific phenotypes
shown by the classic QTL analysis.
Methods
RNA-Seq library construction
All research protocols involving live animals were ap-
proved by the institutional review board of National In-
stitute on Alcohol Abuse and Alcoholism. F1 mice were
generated by reciprocal crosses between C57BL/6J and
three other strains of inbred mice, 129S1/SvlmJ, DBA/2J
and CAST/EiJ (Jackson Laboratories). Eight week old F1
mice, including 6 male mice from each reciprocal cross,
were sacrificed by cervical dislocation. Forebrain and
kidney were dissected and total RNA extracted using the
mirVana miRNA isolation kit (Ambion), according to
the manufacturer’s protocol. Aliquots of total RNA from
all 6 animals for each F1 cross were pooled. To eliminate
residual genomic DNA, RNA samples were incubated
with DNase (Ambion) at 37 °C for 30 min. mRNA was
isolated from 20 μg of total RNA using MicroPoly(A)
Purist kit (Ambion, City, USA) and purified with Ribo-
minus concentration module (Invitrogen). The purified
mRNA was fragmented to 100 ~ 200 bp in length, and
adaptors (Illumina) were ligated before reverse transcrip-
tion to generate libraries according to the protocol of
Ambion RNA-Seq Library construction. cDNA frag-
ments of 200–300 bp were isolated using Novex® 6 %
TBE-Urea Gel. The libraries were amplified by PCR for
16 cycles, quantified by Qubit dsDNA BR (Invitrogen),
and profiled by Bioanalyzer DNA 1000 kit (Agilent).
Exome-seq libraries
Genomic DNA (gDNA) was extracted from spleen of 8
week old mice representing each parental inbred strain
(DBA/2J, CAST/EiJ, 129S1/SvlmJ and C57BL/6J male
mice). 3 μg of gDNA was sheared with Covaris S-series
single tube sample preparation system (Covaris) to 150 bp
fragments. Fragmented gDNA was used to make Exome
libraries using SureSelect XT Mouse All Exon kit (Agilent
Technologies) according to the manufacturer’s protocol.
Briefly, DNA was end-repaired and phosphorylated. After
A-tailing, genomic DNA fragments were ligated to se-
quencing adapters. Ligated genomic DNA fragments were
amplified by PCR for 5 cycles using Herculase II Fusion
DNA Polymerase (Agilent). DNA libraries were purified
with Agencourt® XP® Beads (Beckman Coulter Genomics)
after each enzymatic reaction and the amounts and sizes
of PCR products were measured using an Agilent 2100
Bioanalyzer (Agilent Technologies) and Qubit assays (Life
Technology). Exonic regions were captured by hybridizing
500 ng of genomic DNA libraries with a Sure Select
mouse All Exon bait library (Agilent). Captured libraries
were amplified for 11 cycles by PCR. The exome libraries
were analyzed for fragment sizes and concentrations using
an Agilent Bioanalyzer High Sensitivity DNA kit (Agilent
Technologies) before sequencing.
RNA-Seq and exome-Seq: sequencing and data
processing
5 ng of the RNA-Seq libraries and Exome-Seq libraries
were used for cluster generation on a grafted GAII Flow
Cell, and then sequenced for 36 cycles on the Illumina
GAIIx Genome Analyzer. Sequence was called with
CASAVA v1.8.1 (Illumina), and mapped to the B6 mouse
reference sequence (UCSC mm9) and the alternative ref-
erence based on 129S1/SvlmJ, DBA/2J, and CAST/EiJ
genome sequences (Sanger Institute, REL-1105). SNVs
were identified using CASAVA v1.8.1 with variants
NoCovCutoff option. A total of 125,640 single nucleo-
tide variants (SNV) were identified with minimum
coverage ≥4 and Q (snp) ≥20. SNVs near splicing sites in
introns from RNA-Seq reads were excluded.
To minimize bias caused by differences in genetic dis-
tance between the parental genomes and the reference
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sequence and to improve alignment quality, alternative
references were constructed by substituting known
strain specific SNVs (Sanger Mouse Genomes Project,
REL-1105). Reads of each F1 RNA-Seq were aligned to
the both B6 reference (mm9) and the alternative refer-
ence for the non-B6 parental inbred strain of the F1
mice. The average number of mapped reads from two
references was used as the mapped reads at each SNV.
Finally, we selected SNVs that were confirmed by
Exome-Seq or/and Sanger mouse SNV database and had
number of reads ≥8. Total numbers of reads of all SNVs
in a gene were added up and then significance of DAE
at each gene was assessed by a binomial test. In addition,
False Discovery Rate (FDR) adjusted p-values were ob-
tained by the Benjamini-Hochberg method [51].
Quantitative Sanger sequencing to detect allelic
imbalance in cDNA
Genomic DNA, to be used as a control, was extracted
from spleen of six 129B6F1 and six B6129SF1 male mice
using the SureSelect gDNA Extraction Kit (Agilent Tech-
nologies). Total RNA was extracted from the forebrain
from six 129SB6F1 and six B6129SF1, which were the
same mice for RNA-Seq, using mirVana miRNA isolation
kit (Ambion). cDNA was synthesized by reverse transcrip-
tion of 2 μg of total RNA extracted from the forebrain of
the same mice with High-capacity cDNA Reverse Tran-
scription kits (Applied Biosystems). PCR amplification
was performed using AmpliTaq Gold DNA polymerase
(Applied Biosystems), 10 ng of template, 1 μl of forward
and reverse primer (5 μM each), 2 μl of H2O at 94 °C for
1 min, followed by 40 cycles each at 94 °C for 20 s, 60 °C
for 30 s, 68 °C for 30 s, and a final extension step of 72 °C
for 10 min. Primer sequences are listed in Additional file
1: Table S9. The PCR products (200 ~ 350 bp) were puri-
fied using the USB ExoSAP-IT reagent (Affymetrix) ac-
cording to the protocol and sequenced on an Applied
Biosystems 3730 DNA Analyzer with Big Dye Terminator
Sequencing Mix (Applied Biosystems). In order to meas-
ure DAE in Sanger sequencing electropherograms, areas
under the peaks at target positions were measured using
ImageJ1.46r (Wayne Rasband, National Institutes of
Health, http://imagej.nih.gov/ij/). The allele signals from
the Sanger cDNA sequencing results were normalized
using the allele-specific peak ratios from the Sanger gDNA
sequencing. To test if the B6 allele and 129S allele were
equally expressed, Sanger sequencing data were evaluated
by a one-group t-test with values of B6 allele area/(B6 al-
lele area + 129S allele area). The analyses were undertaken
using JMP11 software (SAS Institute).
Quantitative RT-PCR
As biological replicates, 4 or 5 mice representing each
strain (129S1/SvlmJ and C57BL/6J) (8 week old) were
used to extract total RNA of forebrain with the same
method as described above. Residual genomic DNA con-
tamination was removed by incubation of RNA samples
with DNaseI (Ambion) at 37 °C for 30 min. 2 ug of total
RNA was reverse-transcribed into first strand cDNA
with the High Capacity cDNA reverse transcription kit
(Applied Biosystems) at 25 °C for 10 min, 37 °C for 2 h,
and 85 °C for 5 min, in a 20 μl reaction volume. For
quantitative PCR, 1 μl of cDNA was mixed with gene-
specific primers (0.25 μM final concentration), 2x SYBR
Green master mix (Applied Biosystems) in a 10 μl vol-
ume. Reactions were carried out on the ABI 7900 real-
time PCR system with the following protocol: one cycle
of 95 °C for 3 min, 40 cycles of 95 °C for 15 s and 60 °C
for 1 min. Primer sequences are listed in Additional
file 1: Table S9. Relative gene expression levels for
each sample were calculated using the ΔCt values
(normalized detection threshold). After normalization
with expression of beta-actin, each value of C57BL/6J
and 129S1/SvlmJ was re-normalized based on the
level of gene expression in C57BL/6J. Quantitative
RT-PCR data were assessed by a two-group t-test
(Additional file 1: Table S10).
Behavior and other phenotype-related QTL data
Except for eQTLs, mouse phenotype QTLs, previously
detected in BXD mice or F2 mice generated between
C57BL/6J and DBA/2J, were extracted from the
Mouse Genome Informatics (MGI) database (www.in-
formatics.jax.org/allele/) [29]. We selected QTLs re-
ported with candidate genes, because some QTLs
were not accompanied by a reported candidate gene.
We evaluated the candidate genes for these pheno-
types against the DAE QTLs we detected in B6/
DBAF1 mice. To compare eQTL data with DAE
QTLs, we used BxD brain cis-eQTLs and kidney cis-
eQTLs from ‘QTL miner’ in GeneNetwork (www.ge-
nenetwork.org). BxD brain cis-eQTLs in GeneNetwork
are based on three RNA-Seq datasets (UTHC mouse
BXD whole brain RNA-Seq (Nov12) RPKM Un-
trimmed, UTHC mouse BXD whole brain RNA-Seq
(Nov12) RPKM Trimmed, and UTHC mouse BXD
whole brain RNA-Seq exon level (Nov12)RPKM with
29 BXD RI (recombinant inbred) mice. BXD kidney
cis-eQTLs in GeneNetwork are derived from three
RNA micro array datasets (Mouse Kidney M430V2
Male (Aug06) RMA, Mouse Kidney M430V2 Sex Bal-
anced (Aug06) RMA, and Mouse Kidney M430v2
(Jul06) RMA) with 54 BXD RI (recombinant inbred)
mice. From the expressed genes in brain or kidney,
we collected genes marked in GeneNetwork as ‘cis-
regulated’ and compared each gene symbol with our
B6/DBAF1 DAE QTLs.
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Additional file 1: Table S1. RNA-Seq depth in forebrain and kidney of
reciprocal F1 crosses. Tabl S2. SNVs detected by exome sequencing (Exome)
or/and Sanger mouse SNVs database (Sanger) in three inbred mouse strains.
Table S3. List of imprinted genes containing SNVs, which were observed with
8 reads in forebrain RNAseq. Table S4. Statistically significant evidence of DAE
ratios diverging from 1:1 observed in reciprocal crosses. Table S5. Phenotype-
related QTLs reported in BxD RI mice or F2 mice derived from B6 and DBA.
Table S6. Genes at phenotype QTLs have DAE QTLs. Table S7.
Genes implicated as phenotypic QTLs showing no DAE in (A) forebrain and
(B) kidney of B6/DBA2 F1 mice. Table S8. 16 Imprinted genes (including
four imprinted non-coding RNAs) detected by brain RNA-Seq of B6/CASTF1.
Table S9. Primers for differentially allelic expression analysis or quantitative
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